Both departments will be equipped with specialized professionals and state-of-the-art facilities ensuring the highest standards of care
The approved product has an estimated market size of US$ 268 million for the twelve months ending June 2024, according to IQVIA
GSK and Flagship to jointly fund up to $150 million upfront
Report highlights significant improvements in adolescent well-being in India
Access to breast milk for sick newborns admitted in intensive care units plays a lifesaving role
Integrated Disease Surveillance Programme (IDSP) strengthened to improve disease surveillance and rapid data reporting
Campaign launched to spread awareness regarding dengue prevention and control
Acquisition in line with Mankind’s stated objective to expand its presence in high entry barrier complex portfolios and high potential OTX brands
The drug will be manufactured at the group's formulation manufacturing facility in Ahmedabad SEZ - II, India
Experienced commercial leader takes helm to expand cardiovascular diagnostic company globally and commercialize company’s flagship plaque analysis software
Subscribe To Our Newsletter & Stay Updated
